
Drugmakers’ Secret Weapon To Keep Your Meds Overpriced
Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new report.
Critical coverage on the global financial system and domestic policies that shape the U.S. economy, with a focus on corporate wrongdoing.
Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new report.
Secretive dark money groups are pushing states to redefine methane gas, undermining renewable energy initiatives.
Geolocation data is safe and sound, new parents get a break, one city’s road to reparations, and sports betting giants need to pay up.
UnitedHealth Group’s investors were profiting from its high denial rates. Now, they’re suing to ensure that doesn’t change.
Lawmakers are about to let tech giants issue their own currency — what could go wrong?
The GENIUS Act would require banks to prioritize stablecoin owners over customers if there’s a financial collapse.
The budget reconciliation bill includes an environmentally devastating natural resources giveaway to a Chilean billionaire with close ties to the Trump family.
As Tesla’s sales collapse, Trump’s financial regulators just let Elon Musk’s vehicle company block nearly all shareholder proposals, including on union efforts and climate goals.
The GENIUS Act isn’t just a crypto giveaway — it could turn tech giants into unregulated banks.
Six supposed patient advocacy groups are closely linked to drugmakers and pushing industry-aligned agendas, according to a new report.